Similar articles

• [Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].

  Ibarra JP, Costa de Mello B, Mazza de Pratto N. Ibarra JP, et al. Hoja Tisiol. 1969;26(1):113-26. Hoja Tisiol. 1969. PMID: 5401724 Spanish. No abstract available.
• [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].

  [No authors listed] [No authors listed] Kekkaku. 1972 May;47(5):139-44. Kekkaku. 1972. PMID: 5042532 Japanese. No abstract available.
• [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].

  Ennes Filho E, Azevedo DE, Sayeg F. Ennes Filho E, et al. Rev Bras Med. 1971 Apr;28(4):171-9. Rev Bras Med. 1971. PMID: 5120854 Portuguese. No abstract available.
• Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

  Zierski M. Zierski M. Lung. 1977;154(2):91-102. doi: 10.1007/BF02713523. Lung. 1977. PMID: 323583 Review. No abstract available.
• [Antitubercular chemotherapy].

  Jouveshomme S, Dautzenberg B. Jouveshomme S, et al. Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104. Rev Mal Respir. 1997. PMID: 9496594 Review. French.